CytoSorbents CTSO 深 滬
已收盤 10-03 16:00:00 美东时间
0.984
-0.001
-0.10%
華盛通- 最 高1.02
- 今 開0.988
- 成交量 10.10万股
- 最 低 0.9513
- 昨 收 0.985
- 總市值 6160.86万
- 52周最高 1.61
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 0.7101
- 委 比 -98.63%
- 總股本 6261.04万
- 歷史最高 15.24
- 量 比 1.64
- 振 幅 6.97%
- 歷史最低 0.70
- 每 手 1
- 風險率 0.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.
09-16 21:11
CytoSorbents To Refile De Novo Application For DrugSorb-ATR, Expects FDA Review In Mid-2026
CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on
09-16 19:14
CytoSorbents Provides DrugSorb-ATR Regulatory Update
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surge...
09-16 19:00
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surger...
09-05 19:00
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market...
08-20 19:24
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization PRINCETON, N.J., Aug. 20, 20...
08-20 19:00
Insights Ahead: Myomo's Quarterly Earnings
Myomo (AMEX:MYO) is preparing to release its quarterly earnings on Monday, 2025...
08-09 04:05
Demystifying CytoSorbents: Insights From 5 Analyst Reviews
5 analysts have shared their evaluations of CytoSorbents (NASDAQ:CTSO) during t...
08-08 21:02
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.
08-08 20:28
